Nuts: Natural Pleiotropic Nutraceuticals

Common nuts (tree nuts and peanuts) are energy-dense foods that nature has gifted with a complex matrix of beneficial nutrients and bioactives, including monounsaturated and polyunsaturated fatty acids, high-quality protein, fiber, non-sodium minerals, tocopherols, phytosterols, and antioxidant phen...

Full description

Bibliographic Details
Main Authors: Emilio Ros, Annapoorna Singh, James H. O’Keefe
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/9/3269
id doaj-f6e21bbedf744a5eb4985a1af797f78d
record_format Article
spelling doaj-f6e21bbedf744a5eb4985a1af797f78d2021-09-26T00:53:05ZengMDPI AGNutrients2072-66432021-09-01133269326910.3390/nu13093269Nuts: Natural Pleiotropic NutraceuticalsEmilio Ros0Annapoorna Singh1James H. O’Keefe2Lipid Clinic, Endocrinology and Nutrition Service, Institut d’Investigacions Biomediques August Pi Sunyer, Hospital Clinic, University of Barcelona, 08036 Barcelona, SpainSaint Luke’s Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO 64110, USASaint Luke’s Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO 64110, USACommon nuts (tree nuts and peanuts) are energy-dense foods that nature has gifted with a complex matrix of beneficial nutrients and bioactives, including monounsaturated and polyunsaturated fatty acids, high-quality protein, fiber, non-sodium minerals, tocopherols, phytosterols, and antioxidant phenolics. These nut components synergize to favorably influence metabolic and vascular physiology pathways, ameliorate cardiovascular risk factors and improve cardiovascular prognosis. There is increasing evidence that nuts positively impact myriad other health outcomes as well. Nut consumption is correlated with lower cancer incidence and cancer mortality, and decreased all-cause mortality. Favorable effects on cognitive function and depression have also been reported. Randomized controlled trials consistently show nuts have a cholesterol-lowering effect. Nut consumption also confers modest improvements on glycemic control, blood pressure (BP), endothelial function, and inflammation. Although nuts are energy-dense foods, they do not predispose to obesity, and in fact may even help in weight loss. Tree nuts and peanuts, but not peanut butter, generally produce similar positive effects on outcomes. First level evidence from the PREDIMED trial shows that, in the context of a Mediterranean diet, consumption of 30 g/d of nuts (walnuts, almonds, and hazelnuts) significantly lowered the risk of a composite endpoint of major adverse cardiovascular events (myocardial infarction, stroke, and death from cardiovascular disease) by ≈30% after intervention for 5 y. Impressively, the nut-supplemented diet reduced stroke risk by 45%. As they are rich in salutary bioactive compounds and beneficially impact various health outcomes, nuts can be considered natural pleiotropic nutraceuticals.https://www.mdpi.com/2072-6643/13/9/3269tree nutspeanutsfatty acidsprospective studiesrandomized clinical trialscardiovascular risk
collection DOAJ
language English
format Article
sources DOAJ
author Emilio Ros
Annapoorna Singh
James H. O’Keefe
spellingShingle Emilio Ros
Annapoorna Singh
James H. O’Keefe
Nuts: Natural Pleiotropic Nutraceuticals
Nutrients
tree nuts
peanuts
fatty acids
prospective studies
randomized clinical trials
cardiovascular risk
author_facet Emilio Ros
Annapoorna Singh
James H. O’Keefe
author_sort Emilio Ros
title Nuts: Natural Pleiotropic Nutraceuticals
title_short Nuts: Natural Pleiotropic Nutraceuticals
title_full Nuts: Natural Pleiotropic Nutraceuticals
title_fullStr Nuts: Natural Pleiotropic Nutraceuticals
title_full_unstemmed Nuts: Natural Pleiotropic Nutraceuticals
title_sort nuts: natural pleiotropic nutraceuticals
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2021-09-01
description Common nuts (tree nuts and peanuts) are energy-dense foods that nature has gifted with a complex matrix of beneficial nutrients and bioactives, including monounsaturated and polyunsaturated fatty acids, high-quality protein, fiber, non-sodium minerals, tocopherols, phytosterols, and antioxidant phenolics. These nut components synergize to favorably influence metabolic and vascular physiology pathways, ameliorate cardiovascular risk factors and improve cardiovascular prognosis. There is increasing evidence that nuts positively impact myriad other health outcomes as well. Nut consumption is correlated with lower cancer incidence and cancer mortality, and decreased all-cause mortality. Favorable effects on cognitive function and depression have also been reported. Randomized controlled trials consistently show nuts have a cholesterol-lowering effect. Nut consumption also confers modest improvements on glycemic control, blood pressure (BP), endothelial function, and inflammation. Although nuts are energy-dense foods, they do not predispose to obesity, and in fact may even help in weight loss. Tree nuts and peanuts, but not peanut butter, generally produce similar positive effects on outcomes. First level evidence from the PREDIMED trial shows that, in the context of a Mediterranean diet, consumption of 30 g/d of nuts (walnuts, almonds, and hazelnuts) significantly lowered the risk of a composite endpoint of major adverse cardiovascular events (myocardial infarction, stroke, and death from cardiovascular disease) by ≈30% after intervention for 5 y. Impressively, the nut-supplemented diet reduced stroke risk by 45%. As they are rich in salutary bioactive compounds and beneficially impact various health outcomes, nuts can be considered natural pleiotropic nutraceuticals.
topic tree nuts
peanuts
fatty acids
prospective studies
randomized clinical trials
cardiovascular risk
url https://www.mdpi.com/2072-6643/13/9/3269
work_keys_str_mv AT emilioros nutsnaturalpleiotropicnutraceuticals
AT annapoornasingh nutsnaturalpleiotropicnutraceuticals
AT jameshokeefe nutsnaturalpleiotropicnutraceuticals
_version_ 1716869672144470016